iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Download App
image

The domestic equity barometers are trading with modest gains in early trade amid volatility. The Nifty was trading below the 18,300 mark. At 09:24 IST, the barometer index, the S&P BSE Sensex, was up 128.32 points or 0.21% to 61,351.35. The Nifty 50 index advanced 31.15 points or 0.17% to 18,286.90. Tata Motors (up 2.12%), Bajaj Auto (up 1.10%), ONGC (up 1.06%) and SBI (up […]

image

Rajaram has a thriving experience of over 25 years and a strong track record of leading revenue and growth profitability growth across multiple industries including pharmaceuticals.

image

Greenpanel Industries intimated that the manufacturing operations at its MDF plant in Chittoor, Andhra Pradesh shall remain closed for a period of about eight days (approx.) from 17 January 2022.

image

The average size of harvested shrimps is 18-20 gm in the normal aqua farms, the company said.

image

Dalmia Cement (Bharat) (DCBL), a subsidiary of Dalmia Bharat, commenced commercial production at its Murli Plant in Chandrapur district, Maharashtra.

image

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe, the generic version of Lexiscan?1 Injection, 0.4 mg/5 mL (0.08 mg/mL), of Astellas US, Inc. According to IQVIATM sales data for the 12 month period ending November 2021, the Lexiscan? Injection, 0.4 mg/5 mL (0.08 […]

image

BHEL employees joined the program virtually from multiple locations across the country.

image

Glenmark Pharmaceuticals on Monday announced that it has received tentative approval from the United States Food & Drug Administration for regadenoson injection.

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.